Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster versus Seretide in chronic obstructive pulmonary disease
2009-014410-10Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Foster arm with Seretide arm (2 arms). Primary endpoints: AUC0-30min standardized by time of change from pre-dose in FEV1 after morning inhalation on day 1 and Transition Dyspnoea Index score at day 84. Started Jan 2011; status: completed.
02
Drugs
beclometasone dipropionate + formoterolsalmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-014410-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014410-10.